July 18 - ClinicAid Research Management and Quartesian today announced formation of a joint venture company, Clinesian. The boutique global CRO will strengthen its capabilities providing a full scope of services to the pharmaceutical industry.
"Clinicaid and Quartesian have both benefited from a strong relationship over the past year, and this agreement is a natural extension of that relationship," said Gary Slizgi, CEO. “Both companies have a proven track record in the pharmaceutical industry, ClinicAid will provide the clinical expertise in project management, monitoring, and quality assurance and Quartesian will provide the data management, statistics, and medical writing expertise”. “Our management team is comprised of key leaders in the pharmaceutical industry with several years of pharmaceutical drug development experience”.
"This agreement is key to Clinesian’s goal to become a leading global provider of outsourcing solutions to the pharmaceutical industry," said Benjamin Jackson, COO, Clinesian. “We have developed a business model that offers an experienced regionally based monitoring service for rapid scale-up and a retained Full Time Equivalent model for off-shoring data management and statistical programming.
Clinesian employs more than 50 people worldwide with offices in California, New Jersey, India and the Ukraine. More information on their full service CRO capabilities can be found on the company website at www.clinesian.com or by calling 1-888-441-4541.
ClinicAid Research Management (www.clinicaidusa.com) and Quartesian (www.quartesian.com) will continue to run separate operations.